Page 25 - FINAL PROGRAM

PRECONGRESS COURSE 04
Sunday, 3 July 2016 I Room 101 C
ART in 2020: The next frontier
Organised by the Special Interest Groups Safety and Quality in ART and Stem Cells
COURSE COORDINATOR
Willianne Nelen (The Netherlands), Rita Vassena (Spain)
COURSE DESCRIPTION
Last decade a lot of new developmental steps have been made in fertility and other health care elds. Now it
is the moment they are coming towards us the coming years. Patients will ask for them, but what is the value
of these new developments for daily practice? And what is already know about its quality and safety? These fundamental question will be discussed from the perspective of patients, doctors, basic scientists, embryologists and ethicists.
TARGET AUDIENCE
Clinicians, paramedicals, basic researchers, embryologists and ethicists
EDUCATIONAL NEEDS AND EXPECTED OUTCOMES
The eld of reproductive care moves and evolutes fast. This creates the need for a lot of the professionals to
be informed about all those new techniques and for the opportunity to discuss with their colleagues about the ethical aspects, the opportunities and challenges of these innovations. After reviewing the recent literature within the eld of reproductive medicine and allied health care elds the following program was composed. Visiting
this program will provide you new knowledge on recent development within reproductive medicine. Moreover, it will provide you information about the ethical aspects of these developments and it will give you insight into the opportunities to implement these techniques yes or no in your own clinical practice in a safe way
09:00 - 09:30 09:30 - 09:45 09:45 - 10:15
10:15 - 10:30 10:30 - 11:00 11:00 - 11:30 11:30 - 11:45 11:45 - 12:15 12:15 - 12:30 12:30 - 13:30 13:30 - 14:00 14:00 - 14:15 14:15 - 14:45 14:45 - 15:00 15:00 - 15:30 15:30 - 16:00 16:00 - 16:15 16:15 - 16:45 16:45 - 17:00
Scantrainer: The challenge of simulation – Arianna D’Angelo (United Kingdom) Discussion
PET/CT: A new non invasive approach to evaluate testicular function – Lawrence Dierickx (France)
Discussion
Coffee break
Arti cial gametes: Ready for the clinic? – Bjorn Heindryckx (Belgium) Discussion
Stem cell therapies and the reproductive tract – Filippo Zambelli (Belgium) Discussion
Lunch break
uTransplantation: State of the art – Mats Brännström (Sweden)
Discussion
The impact of reproductive toxicology – Anne Marie Vinggaard (Denmark) Discussion
Coffee break
E-health & social media – Angelique van Dongen (The Netherlands)
Discussion
The technological imperative of reproductive medicine – Heidi Mertes (Belgium) Discussion
FINAL PROGRAMME I HELSINKI, FINLAND – 3 TO 6 JULY 2016 21
PRECONGRESS COURSES